Monsoon comes with its own sets of concerns. While building on immunity has been the topic of discussion for the past year, monsoons tend to affect immunity and the body is susceptible to health issues and prone to infections.
Mumbai based Nutritionist and Lifestyle Educator Karishma Chawla shares a Monsoon food guide and how one can include the right foods to boost one's immunity this season and keep them warm.
Sharing a few guidelines as here under:
1. Add immune booster foods
2. Keep hydration levels high.
3. Add garlic, turmeric in daily foods to enhance immunity
4. Add a probiotic yoghurt to the diet
5. Include warm foods like protein lean meats (egg whites and chicken) and fibre fruits and vegetables to keep the body warm
6. Indulge in seasonal fruits
7. Avoid raw foods
8. Wash vegetables well before cooking
9. Make sure to have your multivitamin and antioxidant supplements every day
10. Make sure to have omega 3 supplements every day
To do or not to do?
With monsoon comes unwanted cravings and refined foods, salty and spicy foods are consumed which can lead to water retention and unhealthy body fat percentages. However, it is important to realize, that a season cannot put a break to your fitness goals. Therefore, it is imperative to follow the optimal level plan of fitness which comprises of:
Eating a balanced diet comprising of complex carbohydrates, lean protein and omega 3 fatty acids
Adequate water and sunshine
Good state of mind- that comes from eating healthy, exercising and spiritual health.
Water retention guidelines:
Keep hydration status high. Thirst is the last indication of the body being dehydrated. If you are well hydrated, you should be urinating about once every 1.5-2 hours.
Add green tea and dandelion tea to the plan- natural diuretics
Parsley and asparagus in food preparations- natural diuretics
Consume calcium rich foods like eggs, low fat milk and milk products and green leafy vegetables
Most importantly avoid table salt.
Read More► Right Nutrition is Paramount
Washington, July 23 (IANS) The US Centers for Disease Control and Prevention (CDC) is considering to incolate all "immunocompromised" people with additional doses of the Covid vaccines, amid surging infections from the Delta variant, the media reported.Members of the Advisory Committee on Immunisation Practices, at a meeting on Thursday, spoke of the urgent need to give additional doses to people with fragile immune systems, as they are more vulnerable to severe Covid outcomes and may also spread the virus to others more frequently, the Washington Post reported.Immunocompromised patients which include organ transplant recipients, people on cancer treatments, and those living with rheumatologic conditions, HIV and leukaemia, represent about 3 per cent of US adults."I think what you're asking about is, you know, is there a way to offer a third dose to individuals a through a study, or through an investigational new drug format for this population? I will just say that we are actively looking into ways that could be done to potentially provide access earlier than any potential change in regulatory decisions," Amanda Cohn, the CDC's chief medical officer for vaccine policy, told panel members.However, the adviosory panel cannot recommend until the US Food and Drug Administration (FDA) gives full approval, the report said. FDA has currently authorised a two-dose regimen of the Pfizer-BioNTech and Moderna vaccines, or a single dose of the Johnson & Johnson shot.As a result, the CDC is exploring a programme that allows sick people to get unapproved drugs until FDA grants the permission, the report added.The programme known as expanded access or, more commonly, compassionate use, can help patients with serious disease or condition get access to investigational new drug/product, that is not FDA-approved. The coronavirus vaccines are considered such products.The process would require enrolling individuals in a clinical study where additional doses can be given, the Post said.Earlier this month, the CDC and FDA released a joint statement on vaccine boosters, saying that people who are fully vaccinated are protected from severe illness and death, including from emerging variants such as the highly contagious Delta variant."FDA, CDC, and NIH (National Institutes of Health) are engaged in a science-based, rigorous process to consider whether or when a booster might be necessary," said the statement.However, studies have suggested that booster dose in immunocompromised people may enhance disease-fighting antibody responses and increase the proportion of those who respond to the vaccines, Sara Oliver, a CDC vaccine expert, told panel members.At a Senate panel hearing this week, Anthony S. Fauci, the US top infectious disease expert, also agreed the need for an additional dose.Immunosuppressed individuals "may actually need a boost as part of their initial regimen, in the sense of getting them up to the point where they are protected", he said.Meanwhile, Israel has rolled out a third dose of the Pfizer-BioNTech coronavirus vaccine to severely immunocompromised adults. Britain has also announced plans for a booster shot to immunosuppressed, people older than 70 and front-line health-care workers in September.--IANSrvt/in
New York, July 18 (IANS) The US researchers have discovered a class of immune cells that plays a role in miscarriage, which affects about a quarter of pregnancies.
Researchers at University of California-San Francisco found that the recently discovered subset of cells known as extrathymic Aire-expressing cells in the immune system may prevent the mother's immune system from attacking the placenta and foetus.
The researchers showed that pregnant mice who did not have this subset of cells were twice as likely to miscarry, and in many of these pregnancies foetal growth was severely restricted.
"When you're pregnant, the immune system is seeing the placenta for the first time in decades -- not since the mother made a placenta when she herself was a foetus," said Eva Gillis-Buck, from UCSF.
"Our research suggests that this subset of immune cells is carrying out a sort of 'secondary education' -- sometimes many years after the better-known population of the educator cells have carried out the primary education in the thymus -- teaching T cells not to attack the foetus, the placenta and other tissues involved in pregnancy," she added. The findings are published in the journal Science Immunology.
The immune system has to be educated not to attack one's own tissues and organs to prevent autoimmune disease. But pregnancy presents a unique challenge, since the foetus expresses proteins found in the placenta as well as proteins whose genetics are distinct from the mother.
"It was a conceptual leap to link Aire-expressing cells, which are critical for preventing autoimmune disease, to pregnancy," said Tippi Mackenzie, Professor of surgery at UCSF's Center for Maternal Foetal Precision Medicine.
In the thymus, Aire-expressing cells begin interacting with other immune cells very early in life to teach them what not to attack. The thymus begins to shrink and is nearly gone by adulthood, by which time most immune cells have been educated. But as the thymus shrinks, the population of eTACs in lymph nodes and the spleen expands, the researchers explained.
The study suggests a healthy pregnancy may depend on having these cells around, they added.
Tel Aviv, July 13 (IANS) Israel has started administering a booster shot of Pfizer's Covid-19 vaccine to people with weak immune systems, the media reported. It is one of the first countries to globally approve a booster shot.The decision for the third jab comes as Israel is witnessing an outbreak of the highly contagious Delta variant, after being one of the first to fully inoculate more than 60 per cent of adults in the country.The Health Ministry will offer the third jab to immunocompromised patients, such as recipients of organ transplants, the Wall Street Journal reported.This is following evidence that the booster shot may increase such patients' antibody counts, according to a Health Ministry letter sent to Israeli healthcare providers, the report said.The Ministry said the recommended time between a second and third shot would be eight weeks, with a minimum gap of four weeks.While the booster shots are not yet rolled out for the general public, the government is, however, weighing the option.Israel is trying to halt a new outbreak of the Delta variant and has launched a campaign calling teenagers over 12 years old to get vaccinated.Although most reported cases have been mild or asymptomatic, there has been a steady rise in the number of infections.On July 11, Israel also signed a deal with Pfizer to receive a new batch of Covid-19 vaccines in August.In a statement at the start of the weekly cabinet meeting, Prime Minister Naftali Bennett said that "last night we closed a deal to bring forward the next shipment of vaccines to August 1", reports Xinhua news agency.He said that together with existing vaccine stocks, the new batch will ensure "from this moment, a continuous inventory of vaccines in Israel".Meanwhile, the US Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), last week, released a joint statement on vaccine boosters, saying that people who are fully vaccinated are protected from severe illness and death, including from emerging variants such as the highly contagious Delta variant."FDA, CDC, and NIH (National Institutes of Health) are engaged in a science-based, rigorous process to consider whether or when a booster might be necessary," said the statement.--IANSrvt/dpb
Jakarta, July 10 (IANS) Indonesia is planning to inject the third doses of Covid-19 vaccine to healthcare workers across the country next week, a minister said.The country's Health Ministry will start the vaccination program using the Moderna Covid-19 vaccine next week, targeting 1.47 million health workers across the country, the Xinhua news agency reported.Indonesia gave its emergency use approval to the Moderna vaccine last Thursday."The Moderna vaccine is planned to come this week and it is hoped that starting next week we can start (the vaccination)," Health Minister Budi Gunadi Sadikin said at a virtual press conference on Friday evening.Sadikin went on to say that the third vaccination will only be given to health workers due to the limited amount of vaccines available."It is important for us to understand that this third vaccination is only given to health workers. Because they are the ones who encounter very high levels of the virus every day and we must protect them to the utmost so that they can concentrate on their works," he said.Health workers in Indonesia have received the second doses of Sinovac Covid-19 vaccines. Until July 3, as many as 6,698 nurses were confirmed to have been infected with coronavirus and 339 of them have died, according to the data provided by National Nurses Association (PPNI).Meanwhile, the Indonesian Medical Association (IDI) said that the number of doctors who have died from coronavirus infections until July 8 is 458 people.On Friday at a separate virtual press conference, head of the IDI's mitigation team Adib Khumaidi said that the number of deaths of doctors infected with the virus have been increasing drastically in the past two months."In May, the number of deaths of doctors increased by seven and it immediately increased in June, 48 doctors. So, it's almost seven times," he said.Indonesia on Friday recorded 38,124 new cases of Covid-19 in the past 24 hours. The total tally is 2.45 million, the country's Health Ministry reported.Meanwhile, the Covid-19-related death toll added by 871 to 64,631. --IANSint/rs
Washington, July 9 (IANS) Pfizer and BioNTech have announced that they were developing a Covid-19 booster shot intended to target the highly transmissible Delta variant, according to US media reports.Concerns continue to rise as the Delta strain has already become the dominant variant in the US, causing increasing infections, Xinhua news agency quoted the reports as saying on Thursday.The two companies said they believe a third shot of their current two-dose vaccine has the potential to preserve the "highest levels" of protection against all currently known variants, including Delta, but they are "remaining vigilant" and developing an updated version of the vaccine, a CNBC News report said."These findings are consistent with an ongoing analysis from the companies' Phase 3 study," the companies said in a statement issued on Thursday. "That is why we have said, and we continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within six to 12 months after full vaccination."Clinical studies could begin as early as August, subject to regulatory approvals, the companies said.Executives from Pfizer and BioNTech have said people will likely need a booster shot, or third dose, within 12 months of getting fully vaccinated because they expect vaccine-induced immunity to wane over time.--IANSksk/